Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Rei, C. Chaves Loureiro, F. Gamboa, C. Robalo Cordeiro (Coimbra, Portugal). Cystic fibrosis: Heartburn and lung function – ²Too hot to handle². Eur Respir J 2012; 40: Suppl. 56, 1115

Member's Comments

No comment yet.

Related content which might interest you: Stenotrophomonas maltophilia and achromobacter xylosoxidans in cystic fibrosis patients Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Lung function in lung cancer – Room for improvement? Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011 Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function? Source: Annual Congress 2010 - Lung function from infancy to adulthood Year: 2010 Respiratory bronchiolitis interstitial lung disease – What is the natural history? Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 LungPoint® – A new approach to peripheral lung lesions Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy Year: 2010 Airway-centered interstitial fibrosis – Two case reports Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 Tuberculoma of the lung – a report of 61 cases Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009 Prevalence and reservoirs of A. xylosoxidans and S. maltophilia in cystic fibrosis center Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 PCD – As serious as CF in every day lung clinic? Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis – Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Eosinophilic pleural effusions – Is everything clear? Source: Annual Congress 2012 - Medical access to the pleura Year: 2012 Interstitial lung diseases in children – Clinical and pathological characteristics Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Hypocarbia in patients with cystic fibrosis – A functional feature to compensate poor oxygenation Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing Year: 2010 Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Destroyed lung secondary to tuberculosis – Surgical options Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 Complex of protease – antiprotease in children with cystic fibrosis Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Lung volume reduction surgery for a decompensated COPD – Case report Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Triple 0 – A new respiratory syndrome? Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts Year: 2012 Clinical analysis of chronic hypersensitivity pneunonitis – Comparison with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Intractable breathlessness in COPD – A suitable case for palliation? Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care Year: 2011